Hemmer der Bruton-Tyrosinkinase

European patent · EP2201840 · In force

Register entry

Publication number
EP2201840
Application number
EP10155834
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 28, 2006
Published
Jun 30, 2010
Granted
Nov 2, 2011
Protection ends at the latest
Dec 27, 2026
Next annual fee due
Dec 31, 2026
IPC classes
A01N 43/90 (2006.01)
A61K 31/519 (2006.01)
C07D 487/04 (2006.01)
A61P 35/00 (2006.01)
Priority
US 826720 P 22.09.2006
US 828590 P 06.10.2006
Divided from
EP06850039
Filing language
English
Source
Swissreg

Supplementary protection certificates

A certificate extends the patent’s protection for a medicine or a plant protection product authorised in Switzerland.

Ibrutinib

C02201840/01 · Medicine · Extended for paediatric use · Protection from Dec 28, 2026 to May 9, 2030

Authorisation 65173 (Swissmedic, Nov 10, 2014) · Authorisation 67109 (Swissmedic, Apr 18, 2019) · Authorisation 65173 (Swissmedic, Dec 14, 2015) · Authorisation 67109 (Swissmedic, Dec 14, 2015)

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Dec 21, 2023

    Address changed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 21.12.2023

  5. Sep 11, 2023

    Address changed

    Owner
    Pharmacyclics LLC, 1 North Waukegan Road, North Chicago, IL 60010, USA → Pharmacyclics LLC, 1 North Waukegan Road, North Chicago, IL 60064, USA

    Published in Swissreg on 11.09.2023

  6. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  7. May 25, 2022

    Address changed

    Owner
    Pharmacyclics LLC, 955 East Arques Avenue, Sunnyvale, CA 94085, USA → Pharmacyclics LLC, 1 North Waukegan Road, North Chicago, IL 60010, USA

    Published in Swissreg on 25.05.2022

  8. Sep 22, 2021

    Corrected

    Owner
    Pharmacyclics, Inc., 995 East Arques Avenue, Sunnyvale, CA 94086, USA → Pharmacyclics, Inc., 995 East Arques Avenue, Sunnyvale, CA 94085, USA

    Published in Swissreg on 22.09.2021

4 earlier entries
  1. Sep 22, 2021

    Change

    Published in Swissreg on 22.09.2021

  2. Jun 8, 2016

    Agent entered

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in Swissreg on 08.06.2016

  3. Jun 8, 2016

    Merged

    Owner
    Pharmacyclics, Inc., 995 East Arques Avenue, Sunnyvale, CA 94085, USA → Pharmacyclics LLC, 955 East Arques Avenue, Sunnyvale, CA 94085, USA

    Published in Swissreg on 08.06.2016

  4. Nov 2, 2011

    Granted

    Published in Swissreg on 02.11.2011

Parties

Holder

Pharmacyclics LLC

1 North Waukegan Road, North Chicago, IL 60064, US

Agent

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

Inventor

Honigberg, Lee

San Francisco, CA 94110, US

Verner, Erik

San Mateo, CA 94401, US

Pan, Zhengying

Alpharetta, GA 30005, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.